Hemab Therapeutics Holdings COAG Income Statement (2024-2026)

NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Hemab Therapeutics Holdings Quarterly Income Statement

Periods 8 quarters
Latest Sep 2026

Hemab Therapeutics Holdings reported net income of -$27.21M for the quarter ended Sep 2026. This income statement covers 8 quarters of results from Dec 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating items
Research & DevelopmentR&D 14.10M12.87M14.56M18.10M19.46M20.34M24.64M
Selling, General & AdministrativeSG&A 2.46M3.18M2.50M2.35M4.15M5.74M5.12M
Other Operating ExpensesOther Opex 1.66M3.85M-0.13M0.66M2.03M-0.24M
Operating ExpensesOpex 16.56M16.06M17.06M20.45M23.61M26.08M29.76M
Operating IncomeOp. Inc -16.56M-16.06M-17.06M-23.61M-26.08M-29.76M
Non-operating items
Interest & Investment IncomeInt & Inv Inc 0.47M0.34M0.22M1.22M2.86M3.38M
Other Non Operating IncomeOther Non Op Inc. 0.59M3.52M-0.13M-0.28M-0.83M-0.24M
Non Operating IncomeNon Op. Inc. 1.06M3.85M0.09M0.94M2.03M3.15M
Net income details
EBIT -16.56M-16.06M-17.06M-23.61M-26.08M-29.76M
EBT -15.50M-12.21M-16.97M-22.68M-24.05M-26.61M
Tax ProvisionsTaxes -0.19M0.00M0.10M0.01M0.10M0.69M
Income After Tax -15.31M-12.21M-17.07M-22.69M-24.15M-27.30M
Income from Continuing OperationsIncome (Continuing) -15.31M-12.21M-17.07M-22.69M-24.15M-27.30M
Consolidated Net IncomeConsol Net Inc. -14.33M-12.82M-17.07M-19.16M-23.30M-26.46M-27.21M
Income towards Parent CompanyParent Net Inc -15.31M-12.21M-17.07M-19.33M-22.69M-24.15M-27.30M
Net Income towards Common StockholdersNet Income -15.31M-12.21M-17.07M-19.33M-22.69M-24.15M-27.30M
Additional items
EPS (Basic) -16.18-12.91-18.04-20.44-23.98-0.80-0.58
EPS (Diluted) -16.18-12.91-18.04-20.44-23.98-0.80-0.58
Shares Outstanding 0.95M0.95M0.95M0.95M0.95M30.11M46.71M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.95M0.95M0.95M0.95M0.95M30.11M46.71M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.95M0.95M0.95M0.95M0.95M0.95M30.11M46.73M
EBITDA -16.49M-15.98M-16.98M-23.54M-26.00M-29.68M

Hemab Therapeutics Holdings Income Statement API

Pull Hemab Therapeutics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=COAG&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY